Inventor · disambiguated record
Guriqbal Basi
Also filed as: BASI GURIQBAL · BASI GURIQBAL S
15 granted patents·11 pending applications·199 citations·filing 1990–2018
93Inventor score
Top patents by PatentIndex Score
26 records- 0192US6627739B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Sep 30, 2003·48 cites·1 claims
- 0291US7262043B2β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Aug 28, 2007·9 cites·4 claims
- 0384US9067981B1Hybrid amyloid-beta antibodiesBASI GURIQBAL·Filed 2009·Granted Jun 30, 2015·18 cites·2 claims
- 0484US7252963B2β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Aug 7, 2007·10 cites·5 claims
- 0583US7276349B2Beta-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Oct 2, 2007·9 cites·3 claims
- 0681US5216132ASoluble t-cell antigen receptor chimeric antigensPROTEIN DESIGN LABS INC·Filed 1990·Granted Jun 1, 1993·54 cites·6 claims
- 0777US7109017B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Sep 19, 2006·13 cites·18 claims
- 0875US7115410B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Oct 3, 2006·16 cites·14 claims
- 0975US7067271B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Jun 27, 2006·12 cites·4 claims
- 1069US2009144840A1Beta-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1166US7718413B2Glycosylation variants of BACEELAN PHARM INC·Filed 2008·Granted May 18, 2010·0 cites·14 claims
- 1263US7482136B2Glycosylation variants of BACEELAN PHARM INC·Filed 2004·Granted Jan 27, 2009·0 cites·17 claims
- 1359US7456007B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 1999·Granted Nov 25, 2008·10 cites·262 claims
- 1457US2011281752A1Beta-secretase enzyme compositions and methodsANDERSON JOHN P·Filed 2011·Application pending·0 cites
- 1555US7427478B2Beta-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Sep 23, 2008·0 cites·6 claims
- 1655US2008300206A1Alpha-Synuclein KinaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1753US2009023158A1Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma SecretaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1849US2011306071A1Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma SecretaseSHAPIRO I PAUL·Filed 2011·Application pending·0 cites
- 1948US2009163594A1Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase InhibitorsELAN PHARM INC·Filed 2008·Application pending·0 cites
- 2048US2012258041A1Compositions and methods for treating diseases of protein aggregation involving ic3b depositionBASI GURIQBAL S·Filed 2012·Application pending·0 cites
- 2148US2014186371A1Compositions and methods for treating diseases of protein aggregation involving ic3b depositionBASI GURIQBAL S·Filed 2012·Application pending·0 cites
- 2246US2014127225A1Compositions and methods for treating diseases of protein aggregation involving ic3b depositionNEOTOPE BIOSCIENCES LTD·Filed 2013·Application pending·0 cites
- 2346US2011207796A1Alpha-synuclein kinaseELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 2440US2008045499A1Preferential Inhibition of Presenilin-1ELAN PHARM INC·Filed 2007·Application pending·0 cites
- 2539US12195529B2Heterodimeric bispecific antibodiesGSBIO LLC·Filed 2018·Granted Jan 14, 2025·0 cites·10 claims
- 2638US8148089B2Alpha-synuclein kinaseANDERSON JOHN P·Filed 2010·Granted Apr 3, 2012·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →